Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine with VRD for Relapsed/Refractory Multiple Myeloma
NCT01484626Phase 2Terminated
- Sponsor
- Loyola University Chicago
- Start
- May 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Loyola University Chicago. Started May 2011; status: terminated.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01484626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484626.